![](/img/cover-not-exists.png)
Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non Small-Cell Lung Cancer
Heymach, J. V., Johnson, B. E., Prager, D., Csada, E., Roubec, J., Pesek, M., Spasova, I., Belani, C. P., Bodrogi, I., Gadgeel, S., Kennedy, S. J., Hou, J., Herbst, R. S.Volume:
25
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2006.10.5122
Date:
August, 2007
File:
PDF, 209 KB
english, 2007